18 research outputs found

    Clinical and laboratory features of iron deficiency in outpatients with Helicobacter Pylori infection

    Get PDF
    The purpose of the study is to identify the clinical features and risk of developing ID in outpatients with H. pylori infection.Цель исследования – выявить клинические особенности и риск развития ЖДС у амбулаторных пациентов с инфекцией H. pylori

    Quality of life in patients with gastroesophageal reflux disease

    Get PDF
    The purpose of the study is to study quality of life in ambulatory patients with gastroesophageal reflux disease.Цель исследования – изучить качество жизни амбулаторных пациентов с гастроэзофагеальной рефлюксной болезнью

    The effect of body mass index on quality of life indicators in elderly and senile patients with diseases of the cardiovascular system

    Get PDF
    The purpose of the study is to determine the effect of body mass index on quality of life indicators in elderly and senile patients with diseases of the cardiovascular system.Цель исследования – определить влияние индекса массы тела на показатели качества жизни у пациентов пожилого и старческого возраста с заболеваниями сердечно-сосудистой системы

    Risk factors for orthorexia nervosa in health professionals

    Get PDF
    The purpose of the study is to identify the prevalence and additional risk factors for ON in healthcare professionals.Цель исследования – выявить распространенность и дополнительные факторы риска НО у медицинских работников

    Research on the prevalence of risk factors of helicobacter pylori infection

    Get PDF
    The article describes the current prevalence of Helicobacter pylori risk factors in YekaterinburgВ статье описаны современные данные по распространенности хеликобактерной инфекции в городе Екатеринбурге в зависимости от пола и возраст

    Prevalence of Helicobacter pylori-associated diseases in the Ural Federal District

    Get PDF
    Introduction Helicobacter pylori has the most pronounced oncogenic potential among known biological carcinogens of humans. Helicobacter positivity leads to the development of chronic gastritis and with prolonged persistence of infection in the gastric mucosa it is associated with the development of atrophic gastritis and adenocarcinoma of the stomach. According to international data, the prevalence of infection in Russia corresponds to the level of countries with low socio-economic status. The domestic literature contains data for a limited number of regions, such as North-West Russia, Siberia and the Far East. The aim of the study was to determine the prevalence of Helicobacter pylori infection and chronic atrophic gastritis among patients residing in the Ural Federal District and to identify risk factors for these diseases using modern diagnostic methods used in clinical practice. Materials and methods Observational non-interventional anonymous cross-sectional study of 11,721 primary patients among those tested for H. pylori infection residing in the Ural Federal District. 13C-urease breath test was performed in 10,882 patients, FGDS with gastric mucosal biopsy according to OLGA and histological evaluation of biopsy specimens – in 839 patients. Results The prevalence of H. pylori infection among primary care patients by 13C-UT was 46.9 % and that of chronic atrophic gastritis by histological evaluation of a biopsy specimen was 24.9 %. The risk of chronic atrophic gastritis was higher in those infected with H. pylori (OR 1.71; 95 % CI: 1.24–2.37, p = 0.002) and in patients over 60 years old. Discussion The resulting prevalence of H. pylori infection in the Ural Federal District is below the levels reported in the current literary for Russia. The increasing prevalence of infection with age confirms the principle that the prevalence of infection depends on changing socio-economic conditions in a generation. The observed prevalence of chronic atrophic gastritis is comparable with the national data. The risk of gastric mucosal atrophy increases with age and in the presence of H. pylori infection, which prompts active screening of gastropathology in this category of individuals. Conclusion The prevalence of H. pylori infection and atrophic gastritis among primary patients, as determined by reference diagnostics, was 46.9 % and 24.9 %, respectively.Введение. Бактерия Helicobacter pylori обладает наиболее выраженным онкогенным потенциалом среди известных биологических канцерогенов человека. Положительный хеликобактерный статус приводит к развитию хронического гастрита и при длительной персистенции инфекции в слизистой оболочке желудка ассоциирован с развитием атрофического гастрита и аденокарциномы желудка. По международным данным, распространенность инфекции в России соответствует уровню стран с низким социально-экономическим статусом. В отечественной литературе присутствуют данные для ограниченного числа регионов: Северо-Западной части России, Сибири и Дальнего Востока. Цель работы – определить распространенность инфекции Helicobacter pylori и хронического атрофического гастрита среди пациентов, проживающих в Уральском федеральном округе, и выявить факторы риска данных заболеваний посредством современных методов диагностики, применяемых в клинической практике. Материалы и методы. Обсервационное неинтервенционное анонимное кросс-секционное исследование 11 721 первичного пациента. Все пациенты, проходившие обследование на инфекцию H. pylori, проживали на территории Уральского федерального округа. 13С-уреазный дыхательный тест выполнен 10 882 больным, ФГДС с биопсией слизистой оболочки желудка по OLGA (англ. Operative Link for Gastritis Assessment) и гистологической оценкой биоптатов – 839 пациентам. Результаты. Распространенность инфекции H. pylori среди пациентов, первично обратившихся за медицинской помощью, по результатам 13С-УДТ составила 46,9 %, а хронического атрофического гастрита по данным гистологической оценки биоптата – 24,9 %. Риск развития хронического атрофического гастрита выше у лиц, инфицированных H. pylori (ОШ 2,25; 95 % ДИ:1,62–3,11, р < 0,001), и пациентов старше 60 лет. Обсуждение. Полученная распространенность инфекции H. pylori в Уральском федеральном округе ниже представленных в современных литературных источниках уровней для России. Нарастание распространенности инфекции с возрастом подтверждает принцип зависимости распространенности инфекции от изменения социально-экономических условий жизни поколения. Выявленная распространенность хронического атрофического гастрита сопоставима с отечественными данными. Риск развития атрофии слизистой оболочки желудка повышается с возрастом и при наличии инфекции H. pylori, что побуждает к активному скринингу гастропатологии у данной категории лиц. Заключение. Распространенность инфекции H. pylori и атрофического гастрита среди первичных пациентов, определенная на основании референсных методов диагностики, составила 46,9 % и 24,9 % соответственно

    Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up

    Get PDF
    Aim. To study the clinical course specifics of coronavirus disease 2019 (COVID-19) and comorbid conditions in COVID-19 survivors 3, 6, 12 months after recovery in the Eurasian region according to the AKTIV register. Material and methods.The AKTIV register was created at the initiative of the Eurasian Association of Therapists. The AKTIV register is divided into 2 parts: AKTIV 1 and AKTIV 2. The AKTIV 1 register currently includes 6300 patients, while in AKTIV 2 — 2770. Patients diagnosed with COVID-19 receiving in- and outpatient treatment have been anonymously included on the registry. The following 7 countries participated in the register: Russian Federation, Republic of Armenia, Republic of Belarus, Republic of Kazakhstan, Kyrgyz Republic, Republic of Moldova, Republic of Uzbekistan. This closed multicenter register with two nonoverlapping branches (in- and outpatient branch) provides 6 visits: 3 in-person visits during the acute period and 3 telephone calls after 3, 6, 12 months. Subject recruitment lasted from June 29, 2020 to October 29, 2020. Register will end on October 29, 2022. A total of 9 fragmentary analyzes of the registry data are planned. This fragment of the study presents the results of the post-hospitalization period in COVID-19 survivors after 3 and 6 months. Results. According to the AKTIV register, patients after COVID-19 are characterized by long-term persistent symptoms and frequent seeking for unscheduled medical care, including rehospitalizations. The most common causes of unplanned medical care are uncontrolled hypertension (HTN) and chronic coronary artery disease (CAD) and/or decompensated type 2 diabetes (T2D). During 3- and 6-month follow-up after hospitalization, 5,6% and 6,4% of patients were diagnosed with other diseases, which were more often presented by HTN, T2D, and CAD. The mortality rate of patients in the post-hospitalization period was 1,9% in the first 3 months and 0,2% for 4-6 months. The highest mortality rate was observed in the first 3 months in the group of patients with class II-IV heart failure, as well as in patients with cardiovascular diseases and cancer. In the pattern of death causes in the post-hospitalization period, following cardiovascular causes prevailed (31,8%): acute coronary syndrome, stroke, acute heart failure. Conclusion. According to the AKTIV register, the health status of patients after COVID-19 in a serious challenge for healthcare system, which requires planning adequate health system capacity to provide care to patients with COVID-19 in both acute and post-hospitalization period
    corecore